earticle

미국 FDA 허가 신약의 시대별 물질 유형과 기업 특성의 변화 동향

현재원, 이상원

한국에프디시규제과학회(구 한국에프디시법제학회) KFDC규제과학회지(구 FDC법제연구) 17권 2호 2022.12 pp.129-136

Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South Korea

Su-Hyun Kim, Ju-Hong Min, Sung-Min Kim, Eun-Jae Lee, Young-Min Lim, Ha Young Shin, Young Nam Kwon, Eunhee Sohn, Sooyoung Kim, Min Su Park, Tai-Seung Nam, Byeol-A Yoon, Jong Kuk Kim, Kyong Jin Shin, Yoo Hwan Kim, Jin Myoung Seok, Jeong Bin Bong, Sohyeon Kim, Hung Youl Seok, Sun-Young Oh, Ohyun Kwon, Sunyoung Kim, Sukyoon Lee, Nam-Hee Kim, Eun Bin Cho, Sa-Yoon Kang, Seong-il Oh, Jong Seok Bae, Suk-Won Ahn, Ki Hoon Kim, You-Ri Kang, Woohee Ju, Seung Ho Choo, Yeon Hak Chung, Jae-Won Hyun, Ho Jin Kim

[NRF 연계] 대한신경과학회 Journal of Clinical Neurology Vol.21 No.2 2025.03 pp.131-136

Investigation of serum biomarkers for neuropathic pain in neuromyelitis optica spectrum disorder: a preliminary study

Jae-Won Hyun, Yeseul Kim, 김호진

[NRF 연계] 대한임상신경생리학회 Annals of Clinical Neurophysiology Vol.23 No.1 2021.04 pp.46-52